Literature DB >> 36214829

Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmia.

Joshua A Keefe1,2, Oliver M Moore1,2, Kevin S Ho1,2, Xander H T Wehrens3,4,5,6,7,8.   

Abstract

Calcium (Ca2+) ions are a key second messenger involved in the rhythmic excitation and contraction of cardiomyocytes throughout the heart. Proper function of Ca2+-handling proteins is required for healthy cardiac function, whereas disruption in any of these can cause cardiac arrhythmias. This comprehensive review provides a broad overview of the roles of Ca2+-handling proteins and their regulators in healthy cardiac function and the mechanisms by which mutations in these proteins contribute to inherited arrhythmias. Major Ca2+ channels and Ca2+-sensitive regulatory proteins involved in cardiac excitation-contraction coupling are discussed, with special emphasis on the function of the RyR2 macromolecular complex. Inherited arrhythmia disorders including catecholaminergic polymorphic ventricular tachycardia, long QT syndrome, Brugada syndrome, short QT syndrome, and arrhythmogenic right-ventricular cardiomyopathy are discussed with particular emphasis on subtypes caused by mutations in Ca2+-handling proteins.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Arrhythmia; Calcium; Catecholaminergic polymorphic ventricular tachycardia; Excitation–contraction coupling; Ryanodine receptor

Year:  2022        PMID: 36214829     DOI: 10.1007/s00204-022-03385-0

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   6.168


  194 in total

1.  Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.

Authors:  Charles Antzelevitch; Guido D Pollevick; Jonathan M Cordeiro; Oscar Casis; Michael C Sanguinetti; Yoshiyasu Aizawa; Alejandra Guerchicoff; Ryan Pfeiffer; Antonio Oliva; Bernd Wollnik; Philip Gelber; Elias P Bonaros; Elena Burashnikov; Yuesheng Wu; John D Sargent; Stefan Schickel; Ralf Oberheiden; Atul Bhatia; Li-Fern Hsu; Michel Haïssaguerre; Rainer Schimpf; Martin Borggrefe; Christian Wolpert
Journal:  Circulation       Date:  2007-01-15       Impact factor: 29.690

2.  Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation.

Authors:  Ravi C Balijepalli; Jason D Foell; Duane D Hall; Johannes W Hell; Timothy J Kamp
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

3.  Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation.

Authors:  Katherina M Alsina; Mohit Hulsurkar; Sören Brandenburg; Daniel Kownatzki-Danger; Christof Lenz; Henning Urlaub; Issam Abu-Taha; Markus Kamler; David Y Chiang; Satadru K Lahiri; Julia O Reynolds; Ann P Quick; Larry Scott; Tarah A Word; Maria D Gelves; Albert J R Heck; Na Li; Dobromir Dobrev; Stephan E Lehnart; Xander H T Wehrens
Journal:  Circulation       Date:  2019-06-12       Impact factor: 29.690

4.  Homozygous/Compound Heterozygous Triadin Mutations Associated With Autosomal-Recessive Long-QT Syndrome and Pediatric Sudden Cardiac Arrest: Elucidation of the Triadin Knockout Syndrome.

Authors:  Helene M Altmann; David J Tester; Melissa L Will; Sumit Middha; Jared M Evans; Bruce W Eckloff; Michael J Ackerman
Journal:  Circulation       Date:  2015-04-28       Impact factor: 29.690

5.  Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness.

Authors:  Shahid M Baig; Alexandra Koschak; Andreas Lieb; Mathias Gebhart; Claudia Dafinger; Gudrun Nürnberg; Amjad Ali; Ilyas Ahmad; Martina J Sinnegger-Brauns; Niels Brandt; Jutta Engel; Matteo E Mangoni; Muhammad Farooq; Habib U Khan; Peter Nürnberg; Jörg Striessnig; Hanno J Bolz
Journal:  Nat Neurosci       Date:  2010-12-05       Impact factor: 24.884

6.  Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs).

Authors:  Michio Asahi; Kazimierz Kurzydlowski; Michihiko Tada; David H MacLennan
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

7.  QT interval variables from 24 hour electrocardiography and the two year risk of sudden death.

Authors:  A Algra; J G Tijssen; J R Roelandt; J Pool; J Lubsen
Journal:  Br Heart J       Date:  1993-07

8.  Optical single-channel resolution imaging of the ryanodine receptor distribution in rat cardiac myocytes.

Authors:  David Baddeley; Isuru D Jayasinghe; Leo Lam; Sabrina Rossberger; Mark B Cannell; Christian Soeller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

9.  Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractility.

Authors:  Gopal J Babu; Poornima Bhupathy; Valeriy Timofeyev; Natalia N Petrashevskaya; Peter J Reiser; Nipavan Chiamvimonvat; Muthu Periasamy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

10.  Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase.

Authors:  Demetrios A Arvanitis; Elizabeth Vafiadaki; Guo-Chang Fan; Bryan A Mitton; Kimberly N Gregory; Federica Del Monte; Aikaterini Kontrogianni-Konstantopoulos; Despina Sanoudou; Evangelia G Kranias
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-05-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.